Showing results (641-650 of 689) with videos related to

Sort By:
Pageof 69
Angewandte Chemie (International Ed. in English)|April 3, 2025
A 3D Hybrid Perovskite Ferroelastic with Triclinic-to-Cubic Phase Transition Boosts Temperature/Pressure Dual On/Off Switchable BirefringenceHuan-Huan Chen, Xiao-Gang Chen, Zhe-Kun Xu, et al.
Cancer Letters|May 3, 2019
A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathwaysQian Dong, Bo Yang, Ju-Guo Han, et al.
Non-Coding RNA Research|May 25, 2026
Functional role of long non-coding RNA MALAT1 and HOTAIR in lung cancerHong-Wei Wen, Ali Afzal, Guang-Wei Chen, et al.
Frontiers in Bioengineering and Biotechnology|March 19, 2021
The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and DisordersEbenezeri Erasto Ngowi, Yi-Zhen Wang, Lei Qian, et al.
BMC Public Health|February 6, 2021
Inequalities in changing mortality and life expectancy in Jiading District, Shanghai, 2002-2018Qian Peng, Na Zhang, Hongjie Yu, et al.
Viruses|January 21, 2023
Evolutionary Origin, Genetic Recombination, and Phylogeography of Porcine KobuvirusYongqiu Cui, Jingyi Li, Jinshuo Guo, et al.
ACS Nano|April 10, 2019
Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization ModelQi Liu, Xiang Wang, Xiangsheng Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
Analyses of GWAS and Sub-Threshold Loci Lead to the Discovery of Dendrite Development and Morphology Dysfunction Underlying Schizophrenia Genetic RiskRui Chen, Benjamin Siciliano, Quan Wang, et al.
BMC Cancer|May 3, 2018
PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathwaysDong-Dong Wu, Ying-Ran Gao, Tao Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 22, 2021
Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1Xiangsheng Liu, Jinhong Jiang, Yu-Pei Liao, et al.
Pageof 69